about
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.A novel approach to leveraging electronic health record data to enhance pediatric surgical quality improvement bundle process compliance.Implementing an Inpatient Pediatric Prospective Audit and Feedback Antimicrobial Stewardship Program Within a Larger Medical Center.Preventing Infections in Children with Cancer.Cytokine responses to QuantiFERON® peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis.Engaging Frontline Staff in Central Line-Associated Bloodstream Infection Prevention Practice in the Wake of Superstorm Sandy.Safety and Effectiveness of Intravenous Pentamidine for Prophylaxis of Pneumocystis jirovecii Pneumonia in Pediatric Hematology/Oncology Patients.Intracranial Mycobacterium abscessus infection in a healthy toddler.Intramedullary schistosomiasis presenting in an adolescent with prolonged intermittent back pain.Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children.Performance of an interferon-gamma release assay to diagnose latent tuberculosis infection during pregnancy.Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistantHyper interleukin-10 in an HIV-positive child with t-cell lymphoma and candidal sepsisLatent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube testA Case of Pott's Puffy Tumor Associated With Barosinusitis From Scuba DivingObesity in patients younger than 60 years is a risk factor for Covid-19 hospital admissionSARS-CoV-2 infection (COVID-19) in febrile infants without respiratory distressDetection of SARS-COV-2 in Placental and Fetal Membrane SamplesNeonatal Intensive Care Unit Preparedness for the Novel Coronavirus Disease-2019 Pandemic: A New York City Hospital Perspective
P50
Q27690864-11BD6C89-5AC7-4922-996B-AC364E10E9B5Q31060959-C8CD1A5A-FAAE-4CB1-97DF-B2B077EE9564Q38621533-31D6E8F4-A977-4E23-9167-831B5CE91D94Q38851043-963323D0-1C85-4BD2-B21F-BF51710B6C95Q39807413-FA4646D7-AA1D-41CE-882A-9C355C8E1D96Q40504530-FB6B95D5-E4D6-4878-826E-68A7AD741688Q40680315-AEB72571-510C-4433-94A2-4064FEA511D5Q42200852-AA1D7B5C-7A07-4F6B-8CBB-1448972F4765Q46772091-672D5963-1829-4432-BF19-CDCF24E02C92Q47750586-862169F6-6347-4D7F-88F2-67FE7A6EC110Q53725551-556C049B-99A1-4EC8-8CB7-40C791377BD6Q62478185-7DD3FE03-0051-4B96-97CE-E7FBBB8F81D4Q82046353-26BBEEA4-72FB-4D3F-843D-4229532EE15EQ83132469-AC466524-CA11-4ED7-B55E-5C3434365B54Q90847943-7F861036-B925-4585-89DF-605FC5E648F6Q91758689-8B1D5B9A-3F05-48B5-899A-92B1BE82CBECQ92013383-D6EDA26A-E33D-4757-AD5B-5A748B0DCDEDQ94548368-04804670-4FF4-40BE-974B-50019EC43E33Q94920156-AE1180CB-A74B-4FE0-8DCA-8F3FB5E715DA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jennifer Lighter
@ast
Jennifer Lighter
@en
Jennifer Lighter
@es
Jennifer Lighter
@nl
type
label
Jennifer Lighter
@ast
Jennifer Lighter
@en
Jennifer Lighter
@es
Jennifer Lighter
@nl
prefLabel
Jennifer Lighter
@ast
Jennifer Lighter
@en
Jennifer Lighter
@es
Jennifer Lighter
@nl
P106
P21
P31
P496
0000-0002-9313-2103